Anhui Huaheng Biotechnology Co. Ltd. A (688639) — Capital Reinvestment Ratio
Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a Capital Reinvestment Ratio of 3.52x as of September 2025, meaning it reinvests 4% of its operating cash flow (CN¥40.01 Million) in capital expenditures (CN¥140.79 Million). See 688639 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anhui Huaheng Biotechnology Co. Ltd. A Capital Reinvestment Ratio (2013–2025)
This chart tracks Anhui Huaheng Biotechnology Co. Ltd. A's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Anhui Huaheng Biotechnology Co. Ltd. A (2013–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Huaheng Biotechnology Co. Ltd. A from 2013 to 2025. For live market cap and broader valuation context, see Anhui Huaheng Biotechnology Co. Ltd. A market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.09x | CN¥104.55 Million | CN¥636.73 Million | ▲ +31.8% |
| 2024 | 4.62x | CN¥199.79 Million | CN¥923.51 Million | ▲ +10.8% |
| 2023 | 4.17x | CN¥304.28 Million | CN¥1.27 Billion | ▲ +226.7% |
| 2022 | 1.28x | CN¥357.43 Million | CN¥456.35 Million | ▼ -32.4% |
| 2021 | 1.89x | CN¥95.70 Million | CN¥180.63 Million | ▲ +184.7% |
| 2020 | 0.66x | CN¥109.57 Million | CN¥72.64 Million | ▲ +47.2% |
| 2019 | 0.45x | CN¥181.48 Million | CN¥81.73 Million | ▼ -36.6% |
| 2018 | 0.71x | CN¥89.31 Million | CN¥63.40 Million | ▲ +56.2% |
| 2017 | 0.45x | CN¥105.69 Million | CN¥48.03 Million | ▼ -57.5% |
| 2016 | 1.07x | CN¥55.02 Million | CN¥58.84 Million | ▼ -58.2% |
| 2015 | 2.56x | CN¥35.27 Million | CN¥90.13 Million | ▲ +301.8% |
| 2014 | 0.64x | CN¥30.56 Million | CN¥19.43 Million | ▲ +16.5% |
| 2013 | 0.55x | CN¥41.21 Million | CN¥22.50 Million | — |